Aptose Biosciences Inc. APTO

Full chart Compare
Set alert

Price alert · APTO

All alert types
1.71 USD 0.00 (+0.00%)

At closeFeb 10, 2026, 4:00 PM EST

1.71 Day range 1.71

52-week range unavailable

YTD
0.00%
1 year
0.00%

Revenue & Expenses

Other Income → Gross Profit & Other Income: $8.10MGross Profit & Other Income → Net Income: $3.94MGross Profit & Other Income → Selling, General & Admin: $2.19MGross Profit & Other Income → Research & Development: $1.86MGross Profit & Other Income → Other Operating Expenses: $193.46KGross Profit & Other Income → Interest Expense: $24.37KGross Profit → Gross Profit & Other Income: $96.73KRevenue → Gross Profit: $96.73KOther Income$8.10MGross Profit$96.73KGross Profit & Other Income$8.20MNet Income$3.94MSelling, General & Admin$2.19MResearch & Development$1.86MOther Operating Expenses$193.46KInterest Expense$24.37KRevenue$96.73K

Latest period ending Dec 31, 2023 · select a line to chart its full history

APTO annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-52.36M-42.60M-65.45M-55.77M-26.86M
-51.21M-41.82M-65.35M-55.24M-26.28M
-227.40-204.00-328.50-301.50-234.00
APTO annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
9.25M36.97M39.11M117.39M79.84M
12.99M51.03M82.53M126.26M100.48M
15.89M13.29M8.29M7.35M6.55M
1.01M1.30M574.00K1.07M1.53M
-2.90M37.74M74.24M118.92M93.93M
APTO annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-44.59M-32.32M-43.30M-33.89M-21.56M
9.96M30.07M-35.21M12.63M-17.37M
6.91M116.00K226.00K58.81M103.45M
-29.00K-24.00K-212.00K-79.00K-102.00K
-27.72M-2.14M-78.28M37.55M64.54M